AIFRED HEALTH TREATS 1ST PATIENT IN NORTH AMERICAN REGULATORY APPROVAL CLINICAL TRIAL – PR Newswire

MONTREAL, June 20, 2022 /PRNewswire/ – Aifred Well being, an award-worthwhile digital healthcare agency, right now introduced the remedy of The primary affected person in its 350 affected person North American Medical Trial. This clinical trial, a world-first Inside the remedy of psychological health using an AI-based mostly clinical choice assist system, was designed with enter from US and Canadian regulatory authorities to validate Aifred’s AI platform To be used with affected particular persons Affected by common to extreme melancholy.  

The trial is being carried out at As a lot as 12 U.S. and Canadian centres of excellence for melancholy remedy collectively with Veterans Affairs (VA) hospitals the place Aifred is a VA evaluation companion. Aifred anticipates To finish enrollment in 2022 and report prime-line Leads to mid 2023.

Aifred’s know-how was developed using Top extreme quality clinical knowledge from clinical trials evaluating therapeutic remedys of melancholy And is not reliant on any exterior look at enters. Aifred’s Computer software was developed with and for treating physicians (household docs and psychiatrists) who right now have restricted models to particular personalize the therapeutic selection for affected particular persons, Ensuing in what’s For A lot of affected particular persons a prolonged and painful trial-and-error course of. Aifred’s Computer software Is meant to assist clinical choice making and enhance this expertise for affected particular persons and clinicians alike.

Commenting on the trial initiation, https://www.prnewswire.com/news-releases/aifred-health-treats-1st-patient-in-north-american-regulatory-approval-clinical-trial-301570784.html

Related Posts

npressfetimg-29461.png

New ‘digital masks’ touted as means of protecting patient privacy – Healthcare Finance News

Photo: Al David Sacks/Getty Images

Technologists writing in the journal Nature have created a digital “mask,” dubbed the DM, which they say offers a pragmatic approach to safeguarding patient privacy in electronic health records and during virtual healthcare visits.

There appear to be clinical benefits to the DM as well.

The technology is based on real-time 3D reconstructio…….

npressfetimg-28933.png

State Rules Stymie Patient Access to Care at Opioid Treatment Centers – PatientEngagementHIT.com

Checking if the site connection is secure

Enable JavaScript and cookies to continue

…….

npressfetimg-28758.png

Top Ranked for Quality & Patient Safety – NYU Langone Health

NYU Langone Health has the highest quality of care and patient safety rankings of any healthcare organization in the country. Each day, we ensure that we are delivering the best in all aspects of care across our hospitals and health system. Our exceptional quality and safety standards have made us the top-rated healthcare system in the New York City area and placed us among the top-ranked …….

npressfetimg-28699.png

COVID-19 rehabilitation patient leaflet hugely popular – World Health Organization

Recognizing early that rehabilitation would be essential for many in their recovery from COVID-19 infection, WHO/Europe quickly convened experts and people recovering from COVID-19 to produce the patient leaflet ‘Support for rehabilitation: self-management after COVID-19-related illness’. 

The resource provides evidence-based support and advice for adults who are recovering from COVI…….

npressfetimg-27757.png

Uninsured, Publicly Insured Patients Face Implicit Bias in Health – PatientEngagementHIT.com

Checking if the site connection is secure

Enable JavaScript and cookies to continue

…….

npressfetimg-27698.png

AI Brings New Opportunities for Patient Financial Navigation – Managed Healthcare Executive

The confusing, data-intensive world of getting help with medical bills has become a fertile territory for software developers.

When patients need help paying for high-cost medical treatment, they face a good news/bad news scenario.

The good news is that drugmakers, private foundations, government agencies and others have myriad programs that can help many if not all. The bad: Actual…….

Leave a Reply

Your email address will not be published. Required fields are marked *